Found: 59
Select item for more details and to access through your institution.
A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project.
- Published in:
- International Journal of Neuropsychopharmacology, 2016, v. 19, n. 4, p. 1, doi. 10.1093/ijnp/pyv121
- By:
- Publication type:
- Article
Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 6, p. 1661, doi. 10.3390/pharmaceutics15061661
- By:
- Publication type:
- Article
Pharmacogenetics of Metformin Transporters Suggests No Association with Therapeutic Inefficacy among Diabetes Type 2 Mexican Patients.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 7, p. N.PAG, doi. 10.3390/ph15070774
- By:
- Publication type:
- Article
Schizophrenia stigma among medical and nursing undergraduates
- Published in:
- 2002
- By:
- Publication type:
- Letter
Association between T102C and A–1438G polymorphisms in the serotonin receptor 2A ( 5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2007, v. 45, n. 7, p. 835, doi. 10.1515/CCLM.2007.181
- By:
- Publication type:
- Article
Third Santorini conference pharmacogenomics workshop report: “Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?”.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2007, v. 45, n. 7, p. 843, doi. 10.1515/CCLM.2007.182
- By:
- Publication type:
- Article
Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2005, v. 43, n. 3, p. 275, doi. 10.1515/CCLM.2005.046
- By:
- Publication type:
- Article
LA TERTULIA DEL PROGRAMA IBEROAMERICANO DE CIENCIA Y TECNOLOGÍA PARA EL DESARROLLO.
- Published in:
- Pan American Journal of Public Health, 2008, v. 23, n. 3, p. 218
- By:
- Publication type:
- Article
Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2002, v. 71, n. 1, p. 89, doi. 10.1067/mcp.2002.121216
- By:
- Publication type:
- Article
Influence of genetic admixture on polymorphisms of drug-metabolizing enzymes: Analyses of mutations on NAT2 and CYP2E1 genes in a mixed Hispanic population<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1998, v. 63, n. 6, p. 623, doi. 10.1016/S0009-9236(98)90085-6
- By:
- Publication type:
- Article
Debrisoquin and mephenytoin hydroxylation phenotypes and CYP2D6 genotype in patients treated with neuroleptic and antidepressant agents.
- Published in:
- Clinical Pharmacology & Therapeutics, 1993, v. 54, n. 6, p. 606, doi. 10.1038/clpt.1993.197
- By:
- Publication type:
- Article
Assessment of the debrisoquin and dextromethorphan phenotyping tests by gaussian mixture distributions analysis.
- Published in:
- Clinical Pharmacology & Therapeutics, 1989, v. 45, n. 3, p. 328, doi. 10.1038/clpt.1989.36
- By:
- Publication type:
- Article
Debrisoquin oxidation polymorphism in a Spanish population.
- Published in:
- Clinical Pharmacology & Therapeutics, 1988, v. 44, n. 1, p. 74, doi. 10.1038/clpt.1988.115
- By:
- Publication type:
- Article
Influence of CYP2D6 Deletion, Multiplication, –1584C→G, 31G→A and 2988G→A Gene Polymorphisms on Dextromethorphan Metabolism among Mexican Tepehuanos and Mestizos.
- Published in:
- Pharmacology, 2010, v. 86, n. 1, p. 30, doi. 10.1159/000314334
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring of Fluoxetine, Norfluoxetine and Paroxetine: A New Tool Based on Microextraction by Packed Sorbent Coupled to Liquid Chromatography.
- Published in:
- Journal of Analytical Toxicology, 2017, v. 41, n. 7, p. 631, doi. 10.1093/jat/bkx043
- By:
- Publication type:
- Article
A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts.
- Published in:
- Translational Psychiatry, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41398-022-02140-4
- By:
- Publication type:
- Article
CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials.
- Published in:
- British Journal of Clinical Pharmacology, 2014, v. 77, n. 4, p. 673, doi. 10.1111/bcp.12227
- By:
- Publication type:
- Article
Impact of cytochrome P450 genes on suicide attempt and risk.
- Published in:
- 2013
- By:
- Publication type:
- Letter
Interethnic differences in UGT1A4 genetic polymorphisms between Mexican Mestizo and Spanish populations.
- Published in:
- Molecular Biology Reports, 2013, v. 40, n. 4, p. 3187, doi. 10.1007/s11033-012-2393-2
- By:
- Publication type:
- Article
Pharmacogenetics of amfepramone in healthy Mexican subjects reveals potential markers for tailoring pharmacotherapy of obesity: results of a randomised trial.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-54436-z
- By:
- Publication type:
- Article
Impact of SLC22A1 variants rs622342 and rs72552763 on HbA1c and metformin plasmatic concentration levels in patients with type 2 diabetes mellitus.
- Published in:
- Biomedical Reports, 2024, v. 21, n. 2, p. N.PAG, doi. 10.3892/br.2024.1806
- By:
- Publication type:
- Article
Frequency of CYP2C9 (*2, *3 and IVS8-109A>T) allelic variants, and their clinical implications, among Mexican patients with diabetes mellitus type 2 undergoing treatment with glibenclamide and metformin.
- Published in:
- Biomedical Reports, 2019, v. 10, n. 5, p. 283
- By:
- Publication type:
- Article
A Call for Clear and Consistent Communications Regarding the Role of Pharmacogenetics in Antidepressant Pharmacotherapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 1, p. 50, doi. 10.1002/cpt.1661
- By:
- Publication type:
- Article
Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 1, p. 257, doi. 10.1002/cpt.1598
- By:
- Publication type:
- Article
CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population.
- Published in:
- European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 637, doi. 10.1007/s00228-011-1147-8
- By:
- Publication type:
- Article
Increased use of second generation antipsychotic drugs in primary care: potential relevance for hospitalizations in schizophrenia patients.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 1, p. 73, doi. 10.1007/s00228-007-0386-1
- By:
- Publication type:
- Article
No effect of the CYP1A2*1F genotype on thioridazine, mesoridazine, sulforidazine plasma concentrations in psychiatric patients.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Effect of CYP2D6 and CYP2C9 genotypes on fluoxetine and norfluoxetine plasma concentrations during steady-state conditions.
- Published in:
- European Journal of Clinical Pharmacology, 2004, v. 59, n. 12, p. 869, doi. 10.1007/s00228-003-0707-y
- By:
- Publication type:
- Article
CYP2C9 genotypes and diclofenac metabolism in Spanish healthy volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 59, n. 3, p. 221, doi. 10.1007/s00228-003-0588-0
- By:
- Publication type:
- Article
Thioridazine steady-state plasma concentrations are influenced by tobacco smoking and CYP2D6, but not by the CYP2C9 genotype.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 59, n. 1, p. 45, doi. 10.1007/s00228-003-0576-4
- By:
- Publication type:
- Article
News in DMPT: Leaders in Pharmacogenetics Section.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Leaders in pharmacogenetics: Urs Albert Meyer.
- Published in:
- Drug Metabolism & Personalized Therapy, 2024, v. 39, n. 1, p. 1, doi. 10.1515/dmpt-2024-0016
- By:
- Publication type:
- Article
Ancestromics.
- Published in:
- Drug Metabolism & Personalized Therapy, 2023, v. 38, n. 4, p. 293, doi. 10.1515/dmpt-2023-0089
- By:
- Publication type:
- Article
Relevance of personalized medicine for improving traditional medicine.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
Pharmacogenetics and ethnicity: "Dr. José María Cantú" award announcement.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
The need of the clinical implementation of pharmacogenetics in European health services for routine drug prescription. What's next? An urgent clinical unmet need for patients.
- Published in:
- Drug Metabolism & Personalized Therapy, 2020, v. 35, n. 4, p. 1, doi. 10.1515/dmpt-2020-0172
- By:
- Publication type:
- Article
Clinical implementation of pharmacogenetics and personalized drug prescription based on e-health: the MedeA initiative.
- Published in:
- Drug Metabolism & Personalized Therapy, 2020, v. 35, n. 3, p. 1, doi. 10.1515/dmpt-2020-0143
- By:
- Publication type:
- Article
Gérard Siest Prize awarded to Alžběta Hlaváčková at the 9th Santorini Conference.
- Published in:
- Drug Metabolism & Personalized Therapy, 2018, v. 33, n. 4, p. 157, doi. 10.1515/dmpt-2018-0035
- By:
- Publication type:
- Article
New perspectives in personalised medicine for ethnicity in cancer: population pharmacogenomics and pharmacometrics.
- Published in:
- Drug Metabolism & Personalized Therapy, 2018, v. 33, n. 2, p. 61, doi. 10.1515/dmpt-2018-0008
- By:
- Publication type:
- Article
Drug-drug interactions. Things to do in pain management.
- Published in:
- Drug Metabolism & Personalized Therapy, 2018, v. 33, n. 1, p. 1, doi. 10.1515/dmpt-2017-0029
- By:
- Publication type:
- Article
An update on HLA alleles associated with adverse drug reactions.
- Published in:
- Drug Metabolism & Personalized Therapy, 2017, v. 32, n. 2, p. 73, doi. 10.1515/dmpt-2016-0025
- By:
- Publication type:
- Article
Pharmacogenomics in pain treatment.
- Published in:
- Drug Metabolism & Personalized Therapy, 2016, v. 31, n. 3, p. 131, doi. 10.1515/dmpt-2016-0005
- By:
- Publication type:
- Article
Interethnic variability of pharmacogenetic biomarkers in Mexican healthy volunteers: a report from the RIBEF (Ibero-American Network of Pharmacogenetics and Pharmacogenomics).
- Published in:
- Drug Metabolism & Personalized Therapy, 2016, v. 31, n. 2, p. 61, doi. 10.1515/dmpt-2015-0030
- By:
- Publication type:
- Article
Predictive biomarkers candidates for patients with metastatic colorectal cancer treated with bevacizumab-containing regimen.
- Published in:
- Drug Metabolism & Personalized Therapy, 2016, v. 31, n. 2, p. 83, doi. 10.1515/dmpt-2015-0027
- By:
- Publication type:
- Article
Progress in pharmacogenetics: consortiums and new strategies.
- Published in:
- Drug Metabolism & Personalized Therapy, 2016, v. 31, n. 1, p. 17, doi. 10.1515/dmpt-2015-0039
- By:
- Publication type:
- Article
Metabolic phenotype prediction from genotyping data: a bottleneck for the implementation of pharmacogenetics in drug development and clinical practice.
- Published in:
- Drug Metabolism & Personalized Therapy, 2015, v. 30, n. 3, p. 143, doi. 10.1515/dmpt-2015-0025
- By:
- Publication type:
- Article
Clinical drug-drug interactions: focus on venlafaxine.
- Published in:
- Drug Metabolism & Personalized Therapy, 2015, v. 30, n. 1, p. 3, doi. 10.1515/dmdi-2014-0011
- By:
- Publication type:
- Article
Population pharmacogenetics and global health.
- Published in:
- Drug Metabolism & Personalized Therapy, 2015, v. 30, n. 2, p. 73, doi. 10.1515/dmdi-2015-0014
- By:
- Publication type:
- Article
Pharmacogenetics in Central American healthy volunteers: interethnic variability.
- Published in:
- Drug Metabolism & Personalized Therapy, 2015, v. 30, n. 1, p. 19, doi. 10.1515/dmdi-2014-0025
- By:
- Publication type:
- Article
CYP2D6 Polymorphism and Mental and Personality Disorders in Suicide Attempters.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article